Prometheus Biosciences Inc. (NASDAQ:RXDX) stock crossing the finish line today

Currently, Prometheus Biosciences Inc.’s (RXDX) stock is trading at $36.61, marking a gain of 1.24% from previous close. At this price, the stock is -29.54% below its 52-week high of $51.96 and 84.99% above its 52-week low of $19.79. Based on the past 30-day period, the stock price is -1.74% below the high and +38.10% above the low.

The 200-day Simple moving average is often placed more emphasis on by traders because of daily price changes. Investors will use the SMA-200 in different situations in trading activity as a key indicator to determine their support and resistance levels, and at the moment, RXDX’s SMA-200 is $33.29.

It is also worth considering a company’s price to sales ratio for the last twelve months, which is 220.36. RXDX’s price to book ratio for the most recent quarter was 6.91, resulting in an 6.12 price to cash per share for the period.

How does Prometheus Biosciences Inc. (RXDX) stock rate among analysts? Buy, sell, or hold?

The key to trading is to concentrate on the future rather than on the past. During uncertain times, it can be hard to make decisions. The analysts who understand how a market works are usually the most accurate at forecasting its future. Currently, there are 9 brokerage firms that recommend the stock as a Strong Buy. The ratings are commonly aggregated into a single number between 1 and 5. Buy or strong buy is scored 5, outperform is scored 4, hold is scored 3, underperform is scored 2 and strong sell is 1. Using a scale of 1-5, the current average recommendation is 4.89 in simple terms.

Prometheus Biosciences Inc. (RXDX): Earnings History

If we examine Prometheus Biosciences Inc.’s recent earnings history, in the last quarter ended on 3/30/2022, it posted adjusted earnings per share of -$0.82, beating the consensus of -$0.79. In other words, it beat the consensus by -$0.03, resulting in a -3.80% surprise. In the 3 months period before the previous quarter which was closed on 3/30/2022, the stock recorded adjusted earnings per share of -$0.82 in contrast with the Outlook of -$0.79. That was a difference of -$0.03 and a surprise of -3.80%.

Prometheus Biosciences Inc. (RXDX): Earnings History

Most analysts expect public companies to report earnings and revenue in line with their projections, but sometimes these figures vary from what they actually expected. In the current quarter, the company had earnings predictions made by 4 different analysts, who are expecting earnings to fall in between the range of -0.88 and -0.95 with an average Earnings Estimate of -0.92 which is in contrast with the last year earnings estimate of -0.49 and also replicates -87.76% growth rate year over year.

Prometheus Biosciences Inc. (NASDAQ: RXDX) Ownership Details

I will give a breakdown of the key shareholders in Prometheus Biosciences Inc. (RXDX). Recent figures show that the company’s insiders hold 23.01% of shares. A total of 160 institutional investors hold shares in the company, making 70.97% of its stock and 92.18% of its float.

Mar 30, 2022, it was reported that the Company’s largest institutional holder is Eventide Asset Management LLC holding total of 3.23 million shares that make 8.25% of the company’s total number of shares and are currently priced at 118.35 million.

The securities firm RTW Investments LP holds 2.76 million shares of RXDX, making it the second largest institutional shareholder. Taking this into account, the holding percentage comes to 7.04%, and the holding percentage of shares is valued at 100.97 million.

An overview of Prometheus Biosciences Inc.’s technicals

Discover Tomorrow's Stocks Today!

When it comes to discovering hidden gems within the stock market, Stock Wire News has consistently provided invaluable insights. Stock Wire News invites you to explore their upcoming Wealth Building Report. This report will shine a spotlight on little-known companies with the potential for substantial growth in 2024, and it's completely FREE for a limited time.

Claim the free report now by clicking here and start discovering the hidden gems of the market
Sponsored

In order to learn about trade movements and investor behavior, it is best to analyze the short, medium, and long term technical indicators along with the average volume of a stock. A 20-day average of the stock’s daily volume suggests Prometheus Biosciences Inc. (RXDX) traded 399,595 shares per day, with a moving average of $30.51 and price change of +7.75. With the moving average of $28.68 and a price change of +13.04, about 459,066 shares changed hands on average over the past 50 days. Finally, RXDX’s 100-day average volume is 438,335 shares, alongside a moving average of $32.23 and a price change of -9.14.

Related Posts